Expanding its healthcare revenue-management services

  • R1 RCM to acquire Acclara for $675 million in cash
  • Providence to receive warrants to purchase 12.2 million shares of R1 stock
  • R1 selected as revenue cycle management partner by Providence

R1 RCM, a leading provider of revenue-management services for healthcare providers, has announced its acquisition of Acclara for $675 million in cash. As part of the deal, Providence, one of the largest hospital systems in the country, will receive warrants to purchase 12.2 million shares of R1 stock. Additionally, Providence has chosen R1 as its revenue cycle management partner for the next 10 years. This acquisition further strengthens R1’s position in the healthcare industry and expands its suite of services.

Public Companies: R1 RCM (R1)
Private Companies: Acclara, Providence
Key People:

Track all markets on TradingView

Factuality Level: 8
Justification: The article provides specific details about the acquisition of Acclara by R1 RCM and the agreement between R1 and Providence. The information is straightforward and does not contain any obvious bias or misleading information. However, without further context or analysis, it is difficult to determine the complete accuracy of the information provided.

Noise Level: 8
Justification: The article provides a brief overview of a business deal between R1 RCM and Acclara, with some details on the financial terms and partnership agreement. However, it lacks in-depth analysis, evidence, or insights into the long-term trends, antifragility, accountability, or scientific rigor. It also does not provide actionable insights or solutions for the reader. Overall, the article contains mostly transactional information without much substance.

Financial Relevance: Yes
Financial Markets Impacted: Healthcare industry

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The news article pertains to a financial transaction between R1 RCM and Acclara, which impacts the healthcare industry. There is no mention of any extreme event in the article.

Reported publicly: www.marketwatch.com